• Pulmonary syndrome in granulomatosis with polyangitis (Wegener granulomatosis) (lecture)

Pulmonary syndrome in granulomatosis with polyangitis (Wegener granulomatosis) (lecture)

SOVREMENNAYA PEDIATRIYA.2017.8(88):120-124; doi 10.15574/SP.2017.88.120

Tsymbalista O. L.
SHEI «IvanoFrankivsk National Medical University», Ukraine

The lecture presents modern views on risk factors, pathogenesis, and the main morphological criteria for granulomatosis with polyangiitis (Wegener granulomatosis). Clinical manifestations, imaging findings of pulmonary syndrome in the aforementioned systemic vasculitis as well as the main diagnostic criteria and the principles of treatment are highlighted in detail.
Key words: Wegener granulomatosis, pulmonary pathology, clinical picture, diagnostics, therapy.

References

1. Beketova TV. (2012). Granulomatosis with polyangiitis, which is pathogenetically associated with antineutrophil cytoplasmic antibodies: clinical features. Rheumatology Science and Practice. 50(6): 19-28. https://doi.org/10.14412/1995-4484-2012-1288

2. Beketova TV. (2014). The current classification of systemic vasculitides. Terapevticheskiy arkhiv. 86(5): 94-98.

3. Belovol AN, Knyazkova II, Shapovalova AV. (2012). Wegener granulomatosis/granulomatosis with polyangiitis. Prakticheskaya onkologiya. 1/2: 16-21.

4. Paleev NR. (2000). Respiratory diseases. Paleev NR, editor. Moscow: Meditsina: 728.

5. Okhotnikova OM, Ponocheieva OV, Mellina KV, Kvacheniuk OH. (2017). Endothelial dysfunction as a risk factor for severe clinical course of systemic vasculitis in children. Klinichna imunolohiia. Alerholohiia. Infektolohiia. 2: 46-52.

6. Zerbino DD, Zimba OO. (2013). Wegener granulomatosis: complications and causes of death. Ukrainian Medical Journal. 5: 127-130.

7. Shtaats G, Khonnef D, Pirot V, Radkov T. (2010). Radiodiagnosis. Childhood diseases. Moscow: MED press-inform: 400.

8. Nasonov YeL, Baranov AA. (1998). Current understanding of the etiology and pathogenesis of systemic vasculitis: the role of infection and genetic predisposition. Part I. Klinicheskaya meditsina. 7: 5-10.

9. Ovsyanikov DYu, Ilnitskaya AS, Akholediani SD. (2015). Hepatopulmonary syndrome in children: clinical observation of granulomatosis with polyangiitis (Wegener granulomatosis) and Goodpasture syndrome. 94(4): 43-57.

10. Gavrisyuk VK. (2016). An essay on clinical pulmonology. Gavrisyuk VK, editor. Kyiv: 336.

11. Semenkova YeN, Krivosheev OG, Novikov PI, Osipenko VI. (2001). Pulmonary involvement in Wegener granulomatosis. 1: 10-13.

12. Chuchalin AG. (2009). Pulmonology: a national guideline. Moscow: GEOTAR-Media: 960.

13. Feshchenko YuI, Yashina LYa. (2008). Rational diagnostics and pharmacotherapy of respiratory diseases. Feshchenko YuI, Yashina LYa, editors. Kyiv: Zdorovye: 265.

14. Nasonova YeL, Nasonova VA. (2008). Rheumatology: a national guideline. Moscow: GEOTAR-Media: 720.

15. Nasonova YeL. (2011). Rheumatology: clinical practice guidelines. Nasonova YeL, editor. Moscow: GEOTAR-Media: 752.

16. Geppe NA, Podchernyaeva NS, Lyskina GA. (2011). Guidelines for pediatric rheumatology. Geppe NA, Podchernyaeva NS, Lyskina GA, editors: 720.

17. Chuchalin AG, Ilkovich MM. (2009). Handbook of pulmonary medicine. Cuchalin AG, Ilkovich MM, editors. Moscow: GEOTAR-Media: 928.

18. Rozinova NN, Mizernitskiy YuL. (2011). Chronic pulmonary diseases in children. Rozinova NN, Mizernitskiy YuL, editors. Moscow: Praktika: 224.

19. Polychronopeulos VS, Prakas UBS, Goblin JM et al. (2005). Airway involvement in Wegener’s granulomatosis. Rheumatic Disease Clinics of North America. 33: 755-775. https://doi.org/10.1016/j.rdc.2007.09.004; PMid:18037115

20. Bouros D, Pneumatikos I, Tzouvelekis A. (2008). Pleural involvement in systemic autoimmune disorders. Respiration. 75: 361-371. https://doi.org/10.1159/000119051; PMid:18477860

21. Hansell DM. (2002). Small-vessel diseases of the lung: CT-pathologic correlates. Radiology. 225: 639-653. https://doi.org/10.1148/radiol.2253011490; PMid:12461242

22. Harper SL. (2001). Wegener’s granulomatosis: the relationship between ocular and systemic disease. Rheumatology. 28: 1025-1026.

23. Lane SE, Waffs R, Scoft DG. (2005). Epidemiology of systemic vasculitis. Current Rheumatology Reports. 7: 270-275. https://doi.org/10.1007/s11926-005-0036-5; PMid:16045829

24. Martinez DPM, Sivasothy P. (2009). Vasculitis of the upper and lower airway. Best Practice & Research Clinical Rheumatology. 23: 403-417. https://doi.org/10.1016/j.berh.2009.02.003; PMid:19508947

25. Pesсi A, Manganelli P. (2007). Respiratory system involvement in antineutrophil cytoplasmic-associated systemic vasculitides. Clinical, patholological, radiological and therapeutic considerations. Rheumatology. 8: 25-42. https://doi.org/10.1093/rheumatology/kei217; PMid:16418204

26. Phillip R, Lugman R. (2008). Mortality in systemic vasculitis. Clinical and Experimental Rheumatology. 26: 94-104.

27. Thickett DR, Richter AG, Nathani N et al. (2006). Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA) – positive vasculitis. Rheumatology. 45: 261-268.

28. Lohrmann C, Uhl ML, Kotter E et al. (2005). Pulmonary manifestations of Wegener granulomatosis: CT findings in 57 patients and a review of the literature. European Journal of Radiology. 53: 471-477. https://doi.org/10.1016/j.ejrad.2004.04.016; PMid:15741022

29. Manganelli P, Fietta P, Garotti M et al. (2006). Respiratory system involvement is systemic vasculitides. Clinical and Experimental Rheumatology. 24(41): 48-59.

30. Savige J. (2000). Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney International. 57: 846-862. https://doi.org/10.1046/j.1523-1755.2000.057003846.x; PMid:10720938

31. Lee KS, Kirn TS, Fujimoto K et al. (2003). Thoracic manifestation of Wegener’s granulomatosis: CT findings in 30 patients. European Radiology. 13: 43-51. PMid:12541109

32. Frankel SK, Cosgrove GP, Fischer A et al. (2006). Update in the diagnosis and management of pulmonary vasculitis. Chest. 129: 452-465. https://doi.org/10.1378/chest.129.2.452; PMid:16478866

33. Jennette JC. (2013). 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatology. 65(1): 1-11. https://doi.org/10.1002/art.37715; PMid:23045170